Sequent Scientific and Viyash Life Sciences will have almost zero net debt after pharma executive turned entrepreneur Hari Babu Bodepudi injects fresh capital following their merger. He is the ...
Sequent Scientific and Viyash Life Sciences are in talks for a potential merger worth Rs. 7000-8000 crore, according to people familiar with the matter.The former is listed and the ...